Trial Profile
Comparative Efficacy of Fixed-dose Combination of Sofosbuvir and Ledipasvir for 8 or 12 Weeks for Chronic Hepatitis C Genotype 6
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 31 Oct 2017 Results published in the American Journal of Gastroenterology
- 12 Oct 2016 Status changed from recruiting to completed.
- 02 Jul 2015 New trial record